Citi Pharma acquisition news highlights the recent CCP approval, paving the way for growth in the pharmaceutical sector.
pharmaceutical news
Avidity acquisition news: The Worst Phase 3 Setback Revealed
Avidity acquisition news reveals the latest Phase 3 setback for Novartis’ dystrophy drug, raising concerns in the pharma industry.